interferon-alpha dimers (IBC)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon-alpha dimers (IBC)
Drug Alias Name20-C2-2bPEG-alpha2b-413IMP-362 (IBC)PEG-alpha2b-362a2b-457 +[7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsAutoimmune DiseasesNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIbc Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIbc Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A